These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9850930)

  • 1. Free radicals in Alzheimer's dementia: currently available therapeutic strategies.
    Rösler M; Retz W; Thome J; Riederer P
    J Neural Transm Suppl; 1998; 54():211-9. PubMed ID: 9850930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's disease.
    Youdim MB; Lavie L
    Life Sci; 1994; 55(25-26):2077-82. PubMed ID: 7527888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegiline.
    Gerlach M; Desser H; Youdim MB; Riederer P
    J Neural Transm Suppl; 1996; 48():7-21. PubMed ID: 8988458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ongoing trials in Alzheimer's disease.
    Sramek JJ; Cutler NR
    Expert Opin Investig Drugs; 2000 Apr; 9(4):899-915. PubMed ID: 11060718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidants and Alzheimer's disease: time to stop feeding vitamin E to dementia patients?
    Ames D; Ritchie C
    Int Psychogeriatr; 2007 Feb; 19(1):1-8. PubMed ID: 17310512
    [No Abstract]   [Full Text] [Related]  

  • 6. Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).
    Wu RM; Mohanakumar KP; Murphy DL; Chiueh CC
    Ann N Y Acad Sci; 1994 Nov; 738():214-21. PubMed ID: 7832430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson's Disease: A Post Hoc Analysis.
    Giladi N; Asgharnejad M; Bauer L; Grieger F; Boroojerdi B
    J Parkinsons Dis; 2016 Apr; 6(2):401-11. PubMed ID: 27061066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin E and Alzheimer disease: the basis for additional clinical trials.
    Grundman M
    Am J Clin Nutr; 2000 Feb; 71(2):630S-636S. PubMed ID: 10681271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future therapeutic approaches to Alzheimer's disease.
    Davis KL
    J Clin Psychiatry; 1998; 59 Suppl 11():14-6. PubMed ID: 9731545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple antioxidants in the prevention and treatment of Parkinson's disease.
    Prasad KN; Cole WC; Kumar B
    J Am Coll Nutr; 1999 Oct; 18(5):413-23. PubMed ID: 10511322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease.
    Praticò D; Delanty N
    Am J Med; 2000 Nov; 109(7):577-85. PubMed ID: 11063960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidative therapeutic strategies for Parkinson's disease.
    Shoulson I
    Ann N Y Acad Sci; 1992 May; 648():37-41. PubMed ID: 1637072
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia.
    Chiueh CC; Wu RM; Mohanakumar KP; Sternberger LM; Krishna G; Obata T; Murphy DL
    Ann N Y Acad Sci; 1994 Nov; 738():25-36. PubMed ID: 7832434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free-radical toxicity and antioxidant medications in Parkinson's disease.
    Ciccone CD
    Phys Ther; 1998 Mar; 78(3):313-9. PubMed ID: 9520976
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxidative stress in Alzheimer's disease: implications for prevention and therapy.
    Behl C
    Subcell Biochem; 2005; 38():65-78. PubMed ID: 15709473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's disease.
    Olanow CW
    Mov Disord; 1993; 8 Suppl 1():S1-7. PubMed ID: 8302302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
    Parnetti L; Senin U; Mecocci P
    Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and Alzheimer disease.
    Christen Y
    Am J Clin Nutr; 2000 Feb; 71(2):621S-629S. PubMed ID: 10681270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention.
    Bagchi D; Bagchi M; Stohs SJ; Das DK; Ray SD; Kuszynski CA; Joshi SS; Pruess HG
    Toxicology; 2000 Aug; 148(2-3):187-97. PubMed ID: 10962138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.
    Halliwell B
    Drugs Aging; 2001; 18(9):685-716. PubMed ID: 11599635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.